Gabapentin enacarbil

• UNSPSC Description:

  Gabapentin enacarbil (XP-13512) is the original drug of gabapentin.

• Target Antigen:

  Calcium Channel

• Type:

  Reference compound

• Related Pathways:

  Membrane Transporter/Ion Channel;Neuronal Signaling

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/Gabapentin-enacarbil.html

• Solubility:

  DMSO : ≥ 100 mg/mL|Ethanol : 100 mg/mL (ultrasonic)

• Smiles:

  O=C(O)CC1(CNC(OC(OC(C(C)C)=O)C)=O)CCCCC1

• Molecular Weight:

  329.39

• References & Citations:

  [1]Cundy KC, et al. XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: I. Design, synthesis, enzymatic conversion to gabapentin, and transport by intestinal solute transporters. J Pharmacol Exp Ther. 2004 Oct;311(1):315-23.|[2]Cundy KC, et al. Clinical pharmacokinetics of XP13512, a novel transported prodrug of gabapentin. J Clin Pharmacol. 2008 Dec;48(12):1378-88.

• Shipping Conditions:

  Blue Ice

• Clinical Information:

  Launched

• CAS Number:

  478296-72-9